Nasaleze products are the world’s first unique powder nasal sprays with intellectual property protection.
Patents
EP(BE)1368090, EP(BE)1824450, BR11201700324703, CA2583794, CN106794137, CN107073230, EP3154515 (FR), EP3154515(GB), EP3154515(IE), EP3154515(IT), EP3154515(DE), EP3154515(PL), EP3154515(ES), EP3154515(SE), EP3154515(TR), EP(FR)3183022, EP(FR)1368090, EP(FR)1824450, EP(DE)602015037234.4, EP(DE)60219442.3, EP(DE)602005037016.1, EP(GB)3183022, EP(GB)1368090, EP(GB)1824450, IN201617042592, IN201717008688, EP(IT)3183022, EP(IT)1368090, EP(IT)1824450, JP6762931, JP6804447, JP5254618, EP(NL)3183022, EP(NL)1368090, EP(NL)1824450, EP(PL)3183022, EP(PL)1824450, RU2016151683, RU2710343, EP(ES)3183022, EP(ES)1368090, EP(ES)1824450, EP(SE)3183022, EP(SE)1368090, EP(SE)1824450, EP(TR)3183022, US2017-0239220, US10,912,902, US7465287, US8202550, US16/657,501, PCT/GB2021/000013, GB2013432.6, Macau J/4665
Trademarks
AU975349, BR828887993, CA A809399, CN845716, EP2922367, EP3778214, IN2775736, JP845716, JP5162953, JP5162954, KR40-1233954, BX845716, MX1670217, NZ719764, NO845716, RU845716, ZA2004/17990, TR2017 71823, GB1514208, GB2372266, GB2922367, GB3778214, US5519879, US6166710, VN4-2020-09490, UK3481641, UK3481651, CN16127793, IL328482, AU1562006, BG1562006, BR1562006, BX1562006, CA1562006, CN 1562006, DE1562006, ES1562006, FR1562006, GR1562006, ID1562006, IN4770648, IT1562006, JP1562006, KR1562006, KZ1252006, MY1562006. MX1562006, PH1562006, PL 1562006, PT1562006, RU1562006, SE1562006, TH1562006, UA1562006, US79298645, VN1562006, AU2148823, BG 1570349, BR1570349, BX1573049, CA2077293, CN1573049, DE1573049, ES1573049, FR1573049, GR1573049, ID1573049, IN4829159/IR, IT1573049, JP1573049, KR1573049, KZ1573049, MY1573049, MX1573049, PH202138911, PL1573049, PT1573049, RU1573049, SE1573049, TH1573049, UA1573049, US79302177, VN1573049, CN44129262, TH200142216, TH200142215, CA2100343, US90203272